+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medistim ASA (MEDI) - Product Pipeline Analysis, 2019 Update

  • PDF Icon

    Company Profile

  • 39 Pages
  • August 2019
  • GlobalData
  • ID: 4455870
Summary

MediStim ASA (MediStim) is a medical device company that manufactures and markets medical products for cardiac, vascular and transplant surgeries. The company’s products include MiraQ cardiac, MiraQ vascular, MiraQ ultimate system, imaging probes, flow probes, VeriQ C and VeriQ systems. Its VeriQ C system combines ultrasound imaging and proven transit time flow measurement in a single system that is designed for cardiovascular procedures. MediStim’s imaging probes are used to visualize blood flow. The company’s VeriQ flowmeter system is designed for intraoperative blood flow measurements during cardiac, vascular and transplant surgery. It operates through its offices located in Norway, Denmark, Germany and the US. MediStim is headquartered in Oslo, Norway.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Medistim ASA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Medistim ASA Company Overview
  • Medistim ASA Company Snapshot
  • Medistim ASA Pipeline Products and Ongoing Clinical Trials Overview
  • Medistim ASA – Pipeline Analysis Overview
  • Medistim ASA - Key Facts
  • Medistim ASA - Major Products and Services
  • Medistim ASA Pipeline Products by Development Stage
  • Medistim ASA Pipeline Products Overview
  • MiraQ Cardiac
  • MiraQ Cardiac Product Overview
  • MiraQ Ultimate
  • MiraQ Ultimate Product Overview
  • MiraQ Vascular
  • MiraQ Vascular Product Overview
  • Medistim ASA - Key Competitors
  • Medistim ASA - Key Employees
  • Medistim ASA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Recent Developments
  • Medistim ASA, Recent Developments
  • Feb 27, 2019: Results for fourth quarter and preliminary results for Medistim for 2018
  • Oct 25, 2018: Medistim: Sales as of September increased by 4.0 % and ended at MOK 228.0 ans revenue from own products showed a currency neutral decline of 0.4 % for the quarter and a currency neutral growth
  • Aug 15, 2018: Medistims: Results for the Second Quarter 2018
  • May 02, 2018: REQUEST Interim Results: Significant Impact on Surgical Strategy with Medistim’s Devices
  • Apr 26, 2018: Medistim: Results for the First Quarter 2018
  • Mar 22, 2018: Medistim: Annual report 2017
  • Mar 16, 2018: Renewed NICE recommendation for adopting Medistim technology in the NHS
  • Mar 15, 2018: Medistim REQUEST Multicenter Registry Study Results to be Presented at AATS in April
  • Feb 15, 2018: Medistim: Results for the Fourth Quarter and Preliminary Results for 2017
  • Oct 23, 2017: Medistim: 3rd Quarter 2017

Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer

List of Tables
  • Medistim ASA Pipeline Products and Ongoing Clinical Trials Overview
  • Medistim ASA Pipeline Products by Equipment Type
  • Medistim ASA Pipeline Products by Indication
  • Medistim ASA, Key Facts
  • Medistim ASA, Major Products and Services
  • Medistim ASA Number of Pipeline Products by Development Stage
  • Medistim ASA Pipeline Products Summary by Development Stage
  • MiraQ Cardiac - Product Status
  • MiraQ Cardiac - Product Description
  • MiraQ Ultimate - Product Status
  • MiraQ Ultimate - Product Description
  • MiraQ Vascular - Product Status
  • MiraQ Vascular - Product Description
  • Medistim ASA, Key Employees
  • Medistim ASA, Other Locations
  • Medistim ASA, Subsidiaries
  • Glossary

List of Figures
  • Medistim ASA Pipeline Products by Equipment Type
  • Medistim ASA Pipeline Products by Development Stage

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Nattopharma ASA
  • Kitron ASA
  • DiaGenic ASA